Related Experiment Videos
Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis
Abstract:
Pneumoccal cell wall and capsular products from eight serotypes were tested for their ability to inhibit polymorphonuclear neutrophil killing of the same eight pneumococcal strains. Crude pneumococcal cell wall preparations from all serotypes inhibited phagocytic killing of several pneumococcal serotypes, and were just as effective with heterologous as with homologous strains. Phagocytosis dependent on heat-labile serum factors was inhibited, whereas phagocytosis not dependent on heat-labile factors was not significantly affected. These findings were compatible with inhibition of complement consumption. The inhibitory activity was found in a purified cell wall mucopeptide, whereas purified capsular polysaccharides failed to inhibit phagocytosis.
Insights
Pneumococcal cell wall components, not capsular polysaccharides, inhibit immune cell killing of pneumococci. This suggests cell walls interfere with complement-mediated bacterial clearance.
Area of Science:
- Immunology
- Microbiology
- Bacterial Pathogenesis
Background:
- * *Streptococcus pneumoniae* (pneumococcus) is a major cause of bacterial infections.
- * Polymorphonuclear neutrophils (PMNs) are key immune cells for clearing pneumococcal infections.
- * Pneumococcal virulence factors can evade immune responses.
Purpose of the Study:
- * To investigate the role of pneumococcal cell wall and capsular products in inhibiting PMN-mediated killing.
- * To determine if inhibitory effects are serotype-specific.
Main Methods:
- * Tested cell wall and capsular extracts from eight pneumococcal serotypes against homologous and heterologous strains.
- * Assessed inhibition of PMN phagocytosis and killing.
- * Differentiated effects on complement-dependent and independent phagocytosis.
Main Results:
- * Crude pneumococcal cell wall preparations inhibited PMN killing of pneumococci across multiple serotypes.
- * Inhibitory activity was observed with both homologous and heterologous strains.
- * Purified cell wall mucopeptides inhibited phagocytosis, while capsular polysaccharides did not.
- * Inhibition was associated with heat-labile serum factors, suggesting complement involvement.
Conclusions:
- * Pneumococcal cell wall mucopeptides, not capsular polysaccharides, are responsible for inhibiting PMN-mediated bacterial clearance.
- * The mechanism likely involves interference with complement activation or function.
- * These findings highlight the cell wall as a critical target for immune evasion by *Streptococcus pneumoniae*.